Education
About Us
Working with TipRanks
Follow Us
Gilla Kaplan Insider Profile
4 Followers
Gilla Kaplan, Director at Celgene, holds 28.23K shares in Tyra Bioscience (Ticker: TYRA), holds 3.17K shares in Avalo Therapeutics (Ticker: AVTX), holds 76.30K shares in Celgene (Ticker: CELG). Most recently, Gilla Kaplan Sold ― shares of Tyra Bioscience on Jun 20, 2025 for an estimated value of 93.68K.
Profitable Transactions
6 out of 9 Profitable Transactions
Average Return
+8.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Gilla Kaplan holds in companies
Most Profitable Insider Trade
Stock:
Celgene
(CELG)
(CELG)
Rating:Informative Buy
Date:Feb 14, 2014 - Feb 14, 2015
Return:+41.30%
The most profitable trade made by Gilla Kaplan
Gilla Kaplan's Trading History
Celgene
Aug 03, 2017
―
Informative Sell
1.01M
$8.26M
Avalo Therapeutics
Apr 01, 2025
Director
Uninformative Buy
26.79K
$24.99K
Tyra Bioscience
Jun 20, 2025
Director
Informative Sell
93.68K
$308.56K
List of latest transactions for each holding click on a transaction to see Gilla Kaplan's performance on stock
You May Also Like
Gilla Kaplan insider profile FAQ
What is the percentage of profitable transactions made by Gilla Kaplan?
The percentage of profitable transactions made by Gilla Kaplan is 67%.
What is the average return per transaction made by Gilla Kaplan?
The average return per transaction made by Gilla Kaplan is 8.80%.
What stocks does Gilla Kaplan hold?
Gilla Kaplan holds: CELG, AVTX, TYRA stocks.
What was Gilla Kaplan’s latest transaction?
Gilla Kaplan latest transaction was an Informative Sell of $93.68K.
What was Gilla Kaplan's most profitable transaction?
Gilla Kaplan’s most profitable transaction was an Informative Buy of CELG stock on February 14, 2014. The return on the trade was 41.30%.
What is Gilla Kaplan's role in Celgene?
Gilla Kaplan's role in Celgene is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.